Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Oncotarget
|
September 8, 2018
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance
Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, et al.
Japanese Journal of Clinical Oncology
|
January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
Tom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
European Journal of Haematology
|
December 16, 2010
Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia
Yao-Yu Hsieh, Ying-Chung Hong, Liang-Tsai Hsiao, et al.
Asian Journal of Surgery
|
September 5, 2024
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma
Su-Hong Wang, Yao-Yu Hsieh, Khaa Hoo Ong, et al.
Journal of Hepatocellular Carcinoma
|
December 1, 2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Chien-Hung Lu, Ching-Wen Chang, San-Chi Chen, et al.
Oncology Letters
|
November 29, 2023
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
Khaa Hoo Ong, Yao-Yu Hsieh, Hong-Yue Lai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2026
SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217)
Nai-Jung Chiang, Yung-Yeh Su, I-Wei Ho, et al.
Scientific Reports
|
October 14, 2023
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
Khaa Hoo Ong, Yao-Yu Hsieh, Hong-Yue Lai, et al.
Frontiers in Oncology
|
December 6, 2021
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment
Hong-Hwa Chen, Tao-Wei Ke, Ching-Wen Huang, et al.
Nutrients
|
July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study
Yu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Oncotarget
|
September 8, 2018
Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance
Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, et al.
Japanese Journal of Clinical Oncology
|
January 10, 2018
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
Tom Wei-Wu Chen, Dah-Cherng Yeh, Tsu-Yi Chao, et al.
European Journal of Haematology
|
December 16, 2010
Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia
Yao-Yu Hsieh, Ying-Chung Hong, Liang-Tsai Hsiao, et al.
Asian Journal of Surgery
|
September 5, 2024
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma
Su-Hong Wang, Yao-Yu Hsieh, Khaa Hoo Ong, et al.
Journal of Hepatocellular Carcinoma
|
December 1, 2025
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
Chien-Hung Lu, Ching-Wen Chang, San-Chi Chen, et al.
Oncology Letters
|
November 29, 2023
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
Khaa Hoo Ong, Yao-Yu Hsieh, Hong-Yue Lai, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 23, 2026
SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217)
Nai-Jung Chiang, Yung-Yeh Su, I-Wei Ho, et al.
Scientific Reports
|
October 14, 2023
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma
Khaa Hoo Ong, Yao-Yu Hsieh, Hong-Yue Lai, et al.
Frontiers in Oncology
|
December 6, 2021
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment
Hong-Hwa Chen, Tao-Wei Ke, Ching-Wen Huang, et al.
Nutrients
|
July 14, 2023
Efficacy and Safety of a Parenteral Nutrition Program for Patients with <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study
Yu-Tang Chang, Chou-Chen Chen, Shih-Ching Chang, et al.
Page
of 5